nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—NOS3—Doxorubicin—ovarian cancer	0.564	1	CbGbCtD
Tetrahydrobiopterin—NOS3—vein—ovarian cancer	0.0283	0.348	CbGeAlD
Tetrahydrobiopterin—PTGS2—ovarian follicle—ovarian cancer	0.0125	0.154	CbGeAlD
Tetrahydrobiopterin—TH—embryo—ovarian cancer	0.00594	0.0731	CbGeAlD
Tetrahydrobiopterin—NOS3—epithelium—ovarian cancer	0.00437	0.0537	CbGeAlD
Tetrahydrobiopterin—TH—endometrium—ovarian cancer	0.00435	0.0535	CbGeAlD
Tetrahydrobiopterin—NOS3—female reproductive system—ovarian cancer	0.00324	0.0399	CbGeAlD
Tetrahydrobiopterin—NOS3—vagina—ovarian cancer	0.00293	0.0361	CbGeAlD
Tetrahydrobiopterin—NOS3—testis—ovarian cancer	0.00262	0.0322	CbGeAlD
Tetrahydrobiopterin—Respiratory failure—Topotecan—ovarian cancer	0.00222	0.0149	CcSEcCtD
Tetrahydrobiopterin—TH—lymph node—ovarian cancer	0.00211	0.0259	CbGeAlD
Tetrahydrobiopterin—Respiratory failure—Vinorelbine—ovarian cancer	0.0019	0.0128	CcSEcCtD
Tetrahydrobiopterin—NOS3—lymph node—ovarian cancer	0.0019	0.0233	CbGeAlD
Tetrahydrobiopterin—Pharyngolaryngeal pain—Paclitaxel—ovarian cancer	0.00186	0.0125	CcSEcCtD
Tetrahydrobiopterin—Laryngeal pain—Paclitaxel—ovarian cancer	0.00184	0.0124	CcSEcCtD
Tetrahydrobiopterin—PTGS2—myometrium—ovarian cancer	0.00176	0.0217	CbGeAlD
Tetrahydrobiopterin—PTGS2—embryo—ovarian cancer	0.0017	0.0208	CbGeAlD
Tetrahydrobiopterin—Infection—Carboplatin—ovarian cancer	0.00169	0.0114	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Altretamine—ovarian cancer	0.00163	0.0109	CcSEcCtD
Tetrahydrobiopterin—Pharyngolaryngeal pain—Docetaxel—ovarian cancer	0.00158	0.0106	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Altretamine—ovarian cancer	0.00156	0.0105	CcSEcCtD
Tetrahydrobiopterin—Laryngeal pain—Docetaxel—ovarian cancer	0.00156	0.0105	CcSEcCtD
Tetrahydrobiopterin—Rhinorrhoea—Paclitaxel—ovarian cancer	0.00155	0.0104	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Vinorelbine—ovarian cancer	0.00154	0.0104	CcSEcCtD
Tetrahydrobiopterin—Nausea—Altretamine—ovarian cancer	0.00146	0.00983	CcSEcCtD
Tetrahydrobiopterin—Contusion—Paclitaxel—ovarian cancer	0.00144	0.00968	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Chlorambucil—ovarian cancer	0.00144	0.00967	CcSEcCtD
Tetrahydrobiopterin—PTGS2—epithelium—ovarian cancer	0.00138	0.017	CbGeAlD
Tetrahydrobiopterin—Oropharyngeal pain—Paclitaxel—ovarian cancer	0.00138	0.00929	CcSEcCtD
Tetrahydrobiopterin—PTGS2—uterine cervix—ovarian cancer	0.00137	0.0169	CbGeAlD
Tetrahydrobiopterin—Body temperature increased—Carboplatin—ovarian cancer	0.00134	0.00904	CcSEcCtD
Tetrahydrobiopterin—Rhinorrhoea—Docetaxel—ovarian cancer	0.00131	0.00884	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Topotecan—ovarian cancer	0.00128	0.00861	CcSEcCtD
Tetrahydrobiopterin—Respiratory failure—Paclitaxel—ovarian cancer	0.00128	0.0086	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Melphalan—ovarian cancer	0.00125	0.00843	CcSEcCtD
Tetrahydrobiopterin—PTGS2—endometrium—ovarian cancer	0.00124	0.0153	CbGeAlD
Tetrahydrobiopterin—Infestation NOS—Topotecan—ovarian cancer	0.00122	0.00821	CcSEcCtD
Tetrahydrobiopterin—Infestation—Topotecan—ovarian cancer	0.00122	0.00821	CcSEcCtD
Tetrahydrobiopterin—Oropharyngeal pain—Docetaxel—ovarian cancer	0.00117	0.00787	CcSEcCtD
Tetrahydrobiopterin—PTGS2—uterus—ovarian cancer	0.00114	0.0141	CbGeAlD
Tetrahydrobiopterin—Urine output increased—Paclitaxel—ovarian cancer	0.00114	0.00764	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Vinorelbine—ovarian cancer	0.00109	0.00737	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Topotecan—ovarian cancer	0.00109	0.00732	CcSEcCtD
Tetrahydrobiopterin—Respiratory failure—Docetaxel—ovarian cancer	0.00108	0.00729	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Vinorelbine—ovarian cancer	0.00104	0.00703	CcSEcCtD
Tetrahydrobiopterin—Infestation—Vinorelbine—ovarian cancer	0.00104	0.00703	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Paclitaxel—ovarian cancer	0.00104	0.00698	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Vinorelbine—ovarian cancer	0.00103	0.00693	CcSEcCtD
Tetrahydrobiopterin—PTGS2—female reproductive system—ovarian cancer	0.00103	0.0126	CbGeAlD
Tetrahydrobiopterin—Myocardial infarction—Vinorelbine—ovarian cancer	0.00102	0.00689	CcSEcCtD
Tetrahydrobiopterin—Nasal congestion—Paclitaxel—ovarian cancer	0.001	0.00673	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Topotecan—ovarian cancer	0.000987	0.00664	CcSEcCtD
Tetrahydrobiopterin—Agitation—Chlorambucil—ovarian cancer	0.000985	0.00662	CcSEcCtD
Tetrahydrobiopterin—PTGS2—bone marrow—ovarian cancer	0.00097	0.0119	CbGeAlD
Tetrahydrobiopterin—Mediastinal disorder—Melphalan—ovarian cancer	0.000967	0.00651	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Topotecan—ovarian cancer	0.000954	0.00642	CcSEcCtD
Tetrahydrobiopterin—PTGS2—female gonad—ovarian cancer	0.000935	0.0115	CbGeAlD
Tetrahydrobiopterin—PTGS2—vagina—ovarian cancer	0.00093	0.0114	CbGeAlD
Tetrahydrobiopterin—Convulsion—Chlorambucil—ovarian cancer	0.000928	0.00625	CcSEcCtD
Tetrahydrobiopterin—Infection—Chlorambucil—ovarian cancer	0.000869	0.00584	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Vinorelbine—ovarian cancer	0.000845	0.00568	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Paclitaxel—ovarian cancer	0.000832	0.0056	CcSEcCtD
Tetrahydrobiopterin—Cough—Topotecan—ovarian cancer	0.000832	0.0056	CcSEcCtD
Tetrahydrobiopterin—Cardiovascular disorder—Epirubicin—ovarian cancer	0.000817	0.0055	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Vinorelbine—ovarian cancer	0.000816	0.00549	CcSEcCtD
Tetrahydrobiopterin—Cough—Melphalan—ovarian cancer	0.000815	0.00548	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Paclitaxel—ovarian cancer	0.000815	0.00548	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Topotecan—ovarian cancer	0.000812	0.00546	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Melphalan—ovarian cancer	0.000809	0.00544	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.000806	0.00543	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00079	0.00531	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Topotecan—ovarian cancer	0.000778	0.00524	CcSEcCtD
Tetrahydrobiopterin—Infection—Topotecan—ovarian cancer	0.000773	0.0052	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.000772	0.0052	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Chlorambucil—ovarian cancer	0.00077	0.00518	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Topotecan—ovarian cancer	0.000763	0.00514	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Melphalan—ovarian cancer	0.000762	0.00513	CcSEcCtD
Tetrahydrobiopterin—Infection—Melphalan—ovarian cancer	0.000757	0.00509	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Topotecan—ovarian cancer	0.000756	0.00509	CcSEcCtD
Tetrahydrobiopterin—Cardiovascular disorder—Doxorubicin—ovarian cancer	0.000756	0.00509	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000755	0.00508	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Melphalan—ovarian cancer	0.00074	0.00498	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Paclitaxel—ovarian cancer	0.000736	0.00496	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Paclitaxel—ovarian cancer	0.000732	0.00493	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000715	0.00481	CcSEcCtD
Tetrahydrobiopterin—Cough—Vinorelbine—ovarian cancer	0.000712	0.00479	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000709	0.00477	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Docetaxel—ovarian cancer	0.000705	0.00475	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Paclitaxel—ovarian cancer	0.000702	0.00473	CcSEcCtD
Tetrahydrobiopterin—Infestation—Paclitaxel—ovarian cancer	0.000702	0.00473	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Vinorelbine—ovarian cancer	0.000695	0.00467	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000694	0.00467	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.000692	0.00466	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Chlorambucil—ovarian cancer	0.000691	0.00465	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Chlorambucil—ovarian cancer	0.000691	0.00465	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Docetaxel—ovarian cancer	0.000691	0.00465	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00069	0.00464	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Paclitaxel—ovarian cancer	0.000688	0.00463	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Topotecan—ovarian cancer	0.000685	0.00461	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Paclitaxel—ovarian cancer	0.000683	0.00459	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000672	0.00452	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Melphalan—ovarian cancer	0.000671	0.00451	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000666	0.00448	CcSEcCtD
Tetrahydrobiopterin—Infection—Vinorelbine—ovarian cancer	0.000662	0.00445	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000658	0.00443	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Vinorelbine—ovarian cancer	0.000653	0.00439	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Vinorelbine—ovarian cancer	0.000647	0.00435	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Chlorambucil—ovarian cancer	0.000644	0.00433	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Topotecan—ovarian cancer	0.000637	0.00428	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Paclitaxel—ovarian cancer	0.000626	0.00421	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Docetaxel—ovarian cancer	0.000624	0.0042	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Paclitaxel—ovarian cancer	0.000621	0.00418	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Topotecan—ovarian cancer	0.000615	0.00414	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Topotecan—ovarian cancer	0.000615	0.00414	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000607	0.00408	CcSEcCtD
Tetrahydrobiopterin—PTGS2—lymph node—ovarian cancer	0.000601	0.00739	CbGeAlD
Tetrahydrobiopterin—Diarrhoea—Chlorambucil—ovarian cancer	0.000598	0.00403	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Docetaxel—ovarian cancer	0.000595	0.00401	CcSEcCtD
Tetrahydrobiopterin—Infestation—Docetaxel—ovarian cancer	0.000595	0.00401	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000587	0.00395	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Docetaxel—ovarian cancer	0.000583	0.00393	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000575	0.00387	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Topotecan—ovarian cancer	0.000574	0.00386	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000568	0.00382	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Melphalan—ovarian cancer	0.000562	0.00378	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Chlorambucil—ovarian cancer	0.000556	0.00374	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Paclitaxel—ovarian cancer	0.000549	0.00369	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000545	0.00366	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Topotecan—ovarian cancer	0.000533	0.00358	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Docetaxel—ovarian cancer	0.00053	0.00357	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Vinorelbine—ovarian cancer	0.000526	0.00354	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Vinorelbine—ovarian cancer	0.000526	0.00354	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Docetaxel—ovarian cancer	0.000526	0.00354	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Melphalan—ovarian cancer	0.000521	0.00351	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000521	0.00351	CcSEcCtD
Tetrahydrobiopterin—Nausea—Chlorambucil—ovarian cancer	0.000519	0.00349	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Topotecan—ovarian cancer	0.000515	0.00346	CcSEcCtD
Tetrahydrobiopterin—Agitation—Paclitaxel—ovarian cancer	0.000504	0.00339	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Topotecan—ovarian cancer	0.000495	0.00333	CcSEcCtD
Tetrahydrobiopterin—Rash—Topotecan—ovarian cancer	0.000491	0.0033	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000491	0.0033	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Topotecan—ovarian cancer	0.00049	0.0033	CcSEcCtD
Tetrahydrobiopterin—Headache—Topotecan—ovarian cancer	0.000488	0.00328	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Melphalan—ovarian cancer	0.000485	0.00326	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000482	0.00324	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Docetaxel—ovarian cancer	0.000482	0.00324	CcSEcCtD
Tetrahydrobiopterin—Rash—Melphalan—ovarian cancer	0.000481	0.00323	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Melphalan—ovarian cancer	0.00048	0.00323	CcSEcCtD
Tetrahydrobiopterin—Cough—Paclitaxel—ovarian cancer	0.000479	0.00322	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Epirubicin—ovarian cancer	0.000476	0.0032	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Paclitaxel—ovarian cancer	0.000475	0.0032	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Paclitaxel—ovarian cancer	0.000467	0.00314	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Epirubicin—ovarian cancer	0.000466	0.00313	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Docetaxel—ovarian cancer	0.000465	0.00313	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000464	0.00312	CcSEcCtD
Tetrahydrobiopterin—Nausea—Topotecan—ovarian cancer	0.000462	0.00311	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Epirubicin—ovarian cancer	0.000461	0.0031	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Vinorelbine—ovarian cancer	0.000456	0.00307	CcSEcCtD
Tetrahydrobiopterin—Nausea—Melphalan—ovarian cancer	0.000453	0.00305	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000448	0.00301	CcSEcCtD
Tetrahydrobiopterin—Infection—Paclitaxel—ovarian cancer	0.000445	0.00299	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Vinorelbine—ovarian cancer	0.00044	0.00296	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00044	0.00296	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Paclitaxel—ovarian cancer	0.000439	0.00296	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Paclitaxel—ovarian cancer	0.000435	0.00293	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000431	0.0029	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Doxorubicin—ovarian cancer	0.000427	0.00287	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Vinorelbine—ovarian cancer	0.000423	0.00285	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Epirubicin—ovarian cancer	0.000421	0.00283	CcSEcCtD
Tetrahydrobiopterin—Rash—Vinorelbine—ovarian cancer	0.00042	0.00283	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Vinorelbine—ovarian cancer	0.000419	0.00282	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000418	0.00282	CcSEcCtD
Tetrahydrobiopterin—Headache—Vinorelbine—ovarian cancer	0.000417	0.00281	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000408	0.00275	CcSEcCtD
Tetrahydrobiopterin—Cough—Docetaxel—ovarian cancer	0.000406	0.00273	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Docetaxel—ovarian cancer	0.000403	0.00271	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Epirubicin—ovarian cancer	0.000401	0.0027	CcSEcCtD
Tetrahydrobiopterin—Infestation—Epirubicin—ovarian cancer	0.000401	0.0027	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Docetaxel—ovarian cancer	0.000396	0.00266	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vinorelbine—ovarian cancer	0.000396	0.00266	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Paclitaxel—ovarian cancer	0.000394	0.00265	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000393	0.00265	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Epirubicin—ovarian cancer	0.00039	0.00263	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Doxorubicin—ovarian cancer	0.00039	0.00262	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000387	0.00261	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000387	0.0026	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Docetaxel—ovarian cancer	0.00038	0.00255	CcSEcCtD
Tetrahydrobiopterin—Infection—Docetaxel—ovarian cancer	0.000377	0.00254	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Docetaxel—ovarian cancer	0.000372	0.00251	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Doxorubicin—ovarian cancer	0.000371	0.0025	CcSEcCtD
Tetrahydrobiopterin—Infestation—Doxorubicin—ovarian cancer	0.000371	0.0025	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Docetaxel—ovarian cancer	0.000369	0.00248	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000366	0.00246	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Doxorubicin—ovarian cancer	0.000361	0.00243	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Epirubicin—ovarian cancer	0.000358	0.00241	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Epirubicin—ovarian cancer	0.000355	0.00239	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Paclitaxel—ovarian cancer	0.000354	0.00238	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Paclitaxel—ovarian cancer	0.000354	0.00238	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000346	0.00233	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Docetaxel—ovarian cancer	0.000334	0.00225	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Doxorubicin—ovarian cancer	0.000331	0.00223	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Paclitaxel—ovarian cancer	0.00033	0.00222	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Doxorubicin—ovarian cancer	0.000329	0.00221	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000328	0.00221	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Epirubicin—ovarian cancer	0.000325	0.00219	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Epirubicin—ovarian cancer	0.000314	0.00211	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00031	0.00209	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Paclitaxel—ovarian cancer	0.000306	0.00206	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000301	0.00202	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Docetaxel—ovarian cancer	0.0003	0.00202	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Docetaxel—ovarian cancer	0.0003	0.00202	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Paclitaxel—ovarian cancer	0.000296	0.00199	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Doxorubicin—ovarian cancer	0.00029	0.00195	CcSEcCtD
Tetrahydrobiopterin—Agitation—Epirubicin—ovarian cancer	0.000288	0.00194	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Paclitaxel—ovarian cancer	0.000285	0.00192	CcSEcCtD
Tetrahydrobiopterin—Rash—Paclitaxel—ovarian cancer	0.000282	0.0019	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Paclitaxel—ovarian cancer	0.000282	0.0019	CcSEcCtD
Tetrahydrobiopterin—Headache—Paclitaxel—ovarian cancer	0.000281	0.00189	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Docetaxel—ovarian cancer	0.00028	0.00188	CcSEcCtD
Tetrahydrobiopterin—Cough—Epirubicin—ovarian cancer	0.000274	0.00184	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Epirubicin—ovarian cancer	0.000272	0.00183	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Epirubicin—ovarian cancer	0.000267	0.0018	CcSEcCtD
Tetrahydrobiopterin—Agitation—Doxorubicin—ovarian cancer	0.000267	0.0018	CcSEcCtD
Tetrahydrobiopterin—Nausea—Paclitaxel—ovarian cancer	0.000266	0.00179	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000265	0.00178	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Docetaxel—ovarian cancer	0.00026	0.00175	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000256	0.00172	CcSEcCtD
Tetrahydrobiopterin—Infection—Epirubicin—ovarian cancer	0.000254	0.00171	CcSEcCtD
Tetrahydrobiopterin—Cough—Doxorubicin—ovarian cancer	0.000253	0.0017	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Doxorubicin—ovarian cancer	0.000252	0.00169	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Epirubicin—ovarian cancer	0.000251	0.00169	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Docetaxel—ovarian cancer	0.000251	0.00169	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Epirubicin—ovarian cancer	0.000249	0.00167	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Doxorubicin—ovarian cancer	0.000247	0.00166	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000245	0.00165	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Docetaxel—ovarian cancer	0.000241	0.00162	CcSEcCtD
Tetrahydrobiopterin—Rash—Docetaxel—ovarian cancer	0.000239	0.00161	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Docetaxel—ovarian cancer	0.000239	0.00161	CcSEcCtD
Tetrahydrobiopterin—Headache—Docetaxel—ovarian cancer	0.000238	0.0016	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000237	0.00159	CcSEcCtD
Tetrahydrobiopterin—Infection—Doxorubicin—ovarian cancer	0.000235	0.00158	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000233	0.00157	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Doxorubicin—ovarian cancer	0.000232	0.00156	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Doxorubicin—ovarian cancer	0.00023	0.00155	CcSEcCtD
Tetrahydrobiopterin—Nausea—Docetaxel—ovarian cancer	0.000225	0.00152	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Epirubicin—ovarian cancer	0.000225	0.00152	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000221	0.00149	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000216	0.00145	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000209	0.00141	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Doxorubicin—ovarian cancer	0.000209	0.0014	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000205	0.00138	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Epirubicin—ovarian cancer	0.000202	0.00136	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Epirubicin—ovarian cancer	0.000202	0.00136	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000194	0.0013	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Epirubicin—ovarian cancer	0.000189	0.00127	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Doxorubicin—ovarian cancer	0.000187	0.00126	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Doxorubicin—ovarian cancer	0.000187	0.00126	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Epirubicin—ovarian cancer	0.000175	0.00118	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000175	0.00117	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Epirubicin—ovarian cancer	0.000169	0.00114	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Epirubicin—ovarian cancer	0.000163	0.0011	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Doxorubicin—ovarian cancer	0.000162	0.00109	CcSEcCtD
Tetrahydrobiopterin—Rash—Epirubicin—ovarian cancer	0.000161	0.00109	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Epirubicin—ovarian cancer	0.000161	0.00109	CcSEcCtD
Tetrahydrobiopterin—Headache—Epirubicin—ovarian cancer	0.00016	0.00108	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Doxorubicin—ovarian cancer	0.000157	0.00105	CcSEcCtD
Tetrahydrobiopterin—Nausea—Epirubicin—ovarian cancer	0.000152	0.00102	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Doxorubicin—ovarian cancer	0.000151	0.00101	CcSEcCtD
Tetrahydrobiopterin—Rash—Doxorubicin—ovarian cancer	0.000149	0.00101	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Doxorubicin—ovarian cancer	0.000149	0.001	CcSEcCtD
Tetrahydrobiopterin—Headache—Doxorubicin—ovarian cancer	0.000148	0.000999	CcSEcCtD
Tetrahydrobiopterin—Nausea—Doxorubicin—ovarian cancer	0.000141	0.000947	CcSEcCtD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CCND1—ovarian cancer	0.000132	0.000642	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PPP1CC—ovarian cancer	0.000129	0.000624	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—CAV1—ovarian cancer	0.000125	0.000608	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PPP2R1A—ovarian cancer	0.000125	0.000605	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—CAV1—ovarian cancer	0.000123	0.000597	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—FASN—ovarian cancer	0.000121	0.000589	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—XIAP—ovarian cancer	0.000121	0.000585	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—HRAS—ovarian cancer	0.000121	0.000585	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—ovarian cancer	0.000119	0.00058	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—SLC5A5—ovarian cancer	0.000119	0.000579	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—TERT—ovarian cancer	0.000118	0.000574	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SMARCA4—ovarian cancer	0.000118	0.00057	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CHMP4C—ovarian cancer	0.000117	0.000565	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—ABCB1—ovarian cancer	0.000116	0.000562	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—SLC2A1—ovarian cancer	0.000115	0.000559	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EREG—ovarian cancer	0.000115	0.000557	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PIK3CG—ovarian cancer	0.000114	0.000554	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—NRAS—ovarian cancer	0.000114	0.000553	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—TYMS—ovarian cancer	0.000114	0.000552	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—PIK3CG—ovarian cancer	0.000112	0.000544	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NME2—ovarian cancer	0.000112	0.000542	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—CYP1B1—ovarian cancer	0.00011	0.000536	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CAV1—ovarian cancer	0.000109	0.000531	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CXCL8—ovarian cancer	0.000108	0.000525	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—AKT1—ovarian cancer	0.000106	0.000516	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—MYC—ovarian cancer	0.000106	0.000515	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000106	0.000513	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CDKN1B—ovarian cancer	0.000106	0.000513	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—IL6ST—ovarian cancer	0.000104	0.000503	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CASP3—ovarian cancer	0.000104	0.000502	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL2—ovarian cancer	0.000103	0.000502	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—YAP1—ovarian cancer	0.000103	0.0005	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—BCL9—ovarian cancer	0.000101	0.00049	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CCND1—ovarian cancer	0.000101	0.000489	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—FASN—ovarian cancer	0.0001	0.000487	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PIK3CD—ovarian cancer	0.0001	0.000487	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PARP1—ovarian cancer	0.0001	0.000485	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.0001	0.000485	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—APC—ovarian cancer	9.97e-05	0.000484	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—PIK3CD—ovarian cancer	9.86e-05	0.000478	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—KRAS—ovarian cancer	9.8e-05	0.000476	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PPP2R1A—ovarian cancer	9.8e-05	0.000475	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MMP9—ovarian cancer	9.79e-05	0.000475	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HDAC6—ovarian cancer	9.74e-05	0.000473	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SLC2A1—ovarian cancer	9.54e-05	0.000463	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	9.47e-05	0.00046	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—CAV1—ovarian cancer	9.16e-05	0.000445	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ABCB1—ovarian cancer	9.1e-05	0.000441	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—TYMS—ovarian cancer	8.93e-05	0.000434	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PIK3CD—ovarian cancer	8.76e-05	0.000425	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PIK3CB—ovarian cancer	8.75e-05	0.000425	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—YAP1—ovarian cancer	8.62e-05	0.000418	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—PIK3CB—ovarian cancer	8.59e-05	0.000417	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—XIAP—ovarian cancer	8.45e-05	0.00041	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—FASN—ovarian cancer	8.41e-05	0.000408	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PIK3CG—ovarian cancer	8.35e-05	0.000405	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—HRAS—ovarian cancer	8.33e-05	0.000404	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MAPK3—ovarian cancer	8.31e-05	0.000403	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—SLC5A5—ovarian cancer	8.27e-05	0.000401	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SMARCA4—ovarian cancer	8.23e-05	0.000399	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PPP2R1A—ovarian cancer	8.11e-05	0.000393	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MYC—ovarian cancer	8.09e-05	0.000392	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EREG—ovarian cancer	8.04e-05	0.00039	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—SLC2A1—ovarian cancer	7.99e-05	0.000388	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MAPK1—ovarian cancer	7.91e-05	0.000384	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—EGFR—ovarian cancer	7.91e-05	0.000384	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—IL2—ovarian cancer	7.89e-05	0.000383	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	7.76e-05	0.000377	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—ERBB2—ovarian cancer	7.74e-05	0.000376	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	7.72e-05	0.000375	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—IL6—ovarian cancer	7.69e-05	0.000373	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CYP1B1—ovarian cancer	7.66e-05	0.000372	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MTOR—ovarian cancer	7.64e-05	0.000371	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PIK3CB—ovarian cancer	7.64e-05	0.000371	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PTEN—ovarian cancer	7.56e-05	0.000367	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PGR—ovarian cancer	7.53e-05	0.000365	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PPP1CC—ovarian cancer	7.51e-05	0.000364	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PIK3CD—ovarian cancer	7.34e-05	0.000356	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—CAV1—ovarian cancer	7.2e-05	0.000349	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYTB—ovarian cancer	7.19e-05	0.000349	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	7.19e-05	0.000349	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CDKN1B—ovarian cancer	7.17e-05	0.000348	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	7.04e-05	0.000342	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.03e-05	0.000341	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PARP1—ovarian cancer	7e-05	0.00034	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	6.86e-05	0.000333	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PPP2R1A—ovarian cancer	6.79e-05	0.00033	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	6.79e-05	0.000329	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CTNNB1—ovarian cancer	6.77e-05	0.000329	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—VEGFA—ovarian cancer	6.7e-05	0.000325	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TP53—ovarian cancer	6.64e-05	0.000322	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—NRAS—ovarian cancer	6.62e-05	0.000321	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	6.62e-05	0.000321	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PTEN—ovarian cancer	6.6e-05	0.00032	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CG—ovarian cancer	6.56e-05	0.000318	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TERT—ovarian cancer	6.44e-05	0.000313	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PIK3CB—ovarian cancer	6.4e-05	0.00031	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—MAPK3—ovarian cancer	6.34e-05	0.000308	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ABCB1—ovarian cancer	6.31e-05	0.000306	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPP1CC—ovarian cancer	6.29e-05	0.000305	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—BRIP1—ovarian cancer	6.29e-05	0.000305	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—TYMS—ovarian cancer	6.19e-05	0.0003	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL6—ovarian cancer	6.08e-05	0.000295	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—MAPK1—ovarian cancer	6.03e-05	0.000293	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	5.98e-05	0.00029	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CAV1—ovarian cancer	5.96e-05	0.000289	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—STAT3—ovarian cancer	5.9e-05	0.000286	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NRAS—ovarian cancer	5.89e-05	0.000286	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CD—ovarian cancer	5.76e-05	0.00028	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—KRAS—ovarian cancer	5.7e-05	0.000277	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HDAC6—ovarian cancer	5.69e-05	0.000276	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PPP2R1A—ovarian cancer	5.68e-05	0.000276	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	5.65e-05	0.000274	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6ST—ovarian cancer	5.65e-05	0.000274	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MAPK3—ovarian cancer	5.64e-05	0.000274	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTEN—ovarian cancer	5.53e-05	0.000268	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	5.5e-05	0.000267	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MYC—ovarian cancer	5.48e-05	0.000266	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—APC—ovarian cancer	5.43e-05	0.000263	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	5.38e-05	0.000261	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	5.38e-05	0.000261	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MAPK1—ovarian cancer	5.37e-05	0.00026	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—EGFR—ovarian cancer	5.36e-05	0.00026	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PIK3CA—ovarian cancer	5.33e-05	0.000259	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—PIK3CA—ovarian cancer	5.24e-05	0.000254	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	5.08e-05	0.000247	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—KRAS—ovarian cancer	5.07e-05	0.000246	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—ovarian cancer	5.07e-05	0.000246	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CB—ovarian cancer	5.02e-05	0.000244	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CAV1—ovarian cancer	4.99e-05	0.000242	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—XIAP—ovarian cancer	4.93e-05	0.000239	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—HRAS—ovarian cancer	4.84e-05	0.000235	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SMARCA4—ovarian cancer	4.81e-05	0.000233	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CD—ovarian cancer	4.77e-05	0.000232	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EREG—ovarian cancer	4.69e-05	0.000228	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	4.67e-05	0.000227	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PIK3CA—ovarian cancer	4.66e-05	0.000226	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.58e-05	0.000222	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CG—ovarian cancer	4.55e-05	0.000221	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	4.52e-05	0.000219	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TERT—ovarian cancer	4.51e-05	0.000219	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—AKT1—ovarian cancer	4.36e-05	0.000211	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTEN—ovarian cancer	4.34e-05	0.000211	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HRAS—ovarian cancer	4.31e-05	0.000209	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—AKT1—ovarian cancer	4.28e-05	0.000208	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—YAP1—ovarian cancer	4.22e-05	0.000205	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ERBB2—ovarian cancer	4.21e-05	0.000204	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.17e-05	0.000203	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CAV1—ovarian cancer	4.17e-05	0.000202	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MTOR—ovarian cancer	4.16e-05	0.000202	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CB—ovarian cancer	4.16e-05	0.000202	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—IL6—ovarian cancer	4.12e-05	0.0002	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FASN—ovarian cancer	4.11e-05	0.000199	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PARP1—ovarian cancer	4.09e-05	0.000198	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ESR1—ovarian cancer	4.02e-05	0.000195	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CD—ovarian cancer	4e-05	0.000194	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6ST—ovarian cancer	3.96e-05	0.000192	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN1B—ovarian cancer	3.9e-05	0.000189	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SLC2A1—ovarian cancer	3.9e-05	0.000189	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PIK3CA—ovarian cancer	3.9e-05	0.000189	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	3.81e-05	0.000185	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—AKT1—ovarian cancer	3.8e-05	0.000185	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APC—ovarian cancer	3.8e-05	0.000184	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CG—ovarian cancer	3.8e-05	0.000184	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CTNNB1—ovarian cancer	3.69e-05	0.000179	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.67e-05	0.000178	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTEN—ovarian cancer	3.59e-05	0.000174	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CB—ovarian cancer	3.48e-05	0.000169	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—FASN—ovarian cancer	3.44e-05	0.000167	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC5A5—ovarian cancer	3.38e-05	0.000164	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CD—ovarian cancer	3.34e-05	0.000162	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PPP2R1A—ovarian cancer	3.32e-05	0.000161	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC2A1—ovarian cancer	3.27e-05	0.000158	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—STAT3—ovarian cancer	3.21e-05	0.000156	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NRAS—ovarian cancer	3.21e-05	0.000156	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.2e-05	0.000155	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—AKT1—ovarian cancer	3.19e-05	0.000155	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP1B1—ovarian cancer	3.13e-05	0.000152	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MAPK3—ovarian cancer	3.07e-05	0.000149	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CA—ovarian cancer	3.06e-05	0.000149	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTEN—ovarian cancer	3.01e-05	0.000146	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MYC—ovarian cancer	2.99e-05	0.000145	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ERBB2—ovarian cancer	2.95e-05	0.000143	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MAPK1—ovarian cancer	2.92e-05	0.000142	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EGFR—ovarian cancer	2.92e-05	0.000142	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MTOR—ovarian cancer	2.91e-05	0.000141	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CB—ovarian cancer	2.91e-05	0.000141	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CXCL8—ovarian cancer	2.8e-05	0.000136	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPP2R1A—ovarian cancer	2.78e-05	0.000135	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.76e-05	0.000134	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—KRAS—ovarian cancer	2.76e-05	0.000134	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN1B—ovarian cancer	2.73e-05	0.000133	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CASP3—ovarian cancer	2.68e-05	0.00013	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL2—ovarian cancer	2.67e-05	0.00013	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TERT—ovarian cancer	2.63e-05	0.000128	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCND1—ovarian cancer	2.61e-05	0.000127	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CTNNB1—ovarian cancer	2.58e-05	0.000125	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCB1—ovarian cancer	2.58e-05	0.000125	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CA—ovarian cancer	2.54e-05	0.000123	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TYMS—ovarian cancer	2.53e-05	0.000123	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MMP9—ovarian cancer	2.53e-05	0.000123	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTEN—ovarian cancer	2.52e-05	0.000122	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—AKT1—ovarian cancer	2.5e-05	0.000121	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CAV1—ovarian cancer	2.44e-05	0.000118	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HRAS—ovarian cancer	2.35e-05	0.000114	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6ST—ovarian cancer	2.31e-05	0.000112	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—VEGFA—ovarian cancer	2.27e-05	0.00011	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—STAT3—ovarian cancer	2.25e-05	0.000109	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NRAS—ovarian cancer	2.25e-05	0.000109	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6—ovarian cancer	2.24e-05	0.000109	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APC—ovarian cancer	2.22e-05	0.000108	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAPK3—ovarian cancer	2.15e-05	0.000104	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CA—ovarian cancer	2.12e-05	0.000103	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MYC—ovarian cancer	2.09e-05	0.000101	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—AKT1—ovarian cancer	2.07e-05	0.0001	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAPK1—ovarian cancer	2.05e-05	9.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EGFR—ovarian cancer	2.05e-05	9.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CAV1—ovarian cancer	2.04e-05	9.9e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CD—ovarian cancer	1.95e-05	9.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.95e-05	9.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KRAS—ovarian cancer	1.93e-05	9.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CG—ovarian cancer	1.86e-05	9.02e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CA—ovarian cancer	1.78e-05	8.61e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—AKT1—ovarian cancer	1.73e-05	8.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB2—ovarian cancer	1.72e-05	8.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—ovarian cancer	1.72e-05	8.33e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTOR—ovarian cancer	1.7e-05	8.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CB—ovarian cancer	1.7e-05	8.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HRAS—ovarian cancer	1.64e-05	7.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CD—ovarian cancer	1.63e-05	7.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN1B—ovarian cancer	1.6e-05	7.74e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6—ovarian cancer	1.57e-05	7.63e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CTNNB1—ovarian cancer	1.51e-05	7.32e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PTEN—ovarian cancer	1.47e-05	7.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKT1—ovarian cancer	1.45e-05	7.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CB—ovarian cancer	1.42e-05	6.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—STAT3—ovarian cancer	1.31e-05	6.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NRAS—ovarian cancer	1.31e-05	6.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MAPK3—ovarian cancer	1.26e-05	6.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PTEN—ovarian cancer	1.23e-05	5.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MYC—ovarian cancer	1.22e-05	5.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MAPK1—ovarian cancer	1.19e-05	5.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EGFR—ovarian cancer	1.19e-05	5.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KRAS—ovarian cancer	1.13e-05	5.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CA—ovarian cancer	1.04e-05	5.03e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HRAS—ovarian cancer	9.59e-06	4.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6—ovarian cancer	9.18e-06	4.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CA—ovarian cancer	8.68e-06	4.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKT1—ovarian cancer	8.47e-06	4.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AKT1—ovarian cancer	7.09e-06	3.44e-05	CbGpPWpGaD
